Fresenius Kabi USA Dexmedetomidine HCL 在 0.9％氯化钠注射液中-由于与利多卡因交叉污染而召回, USA

3年前 •source www.fda.gov

Recall notice

Fresenius Kabi USA Dexmedetomidine HCL in 0.9% Sodium Chloride Injection - recalled due to cross contamination with Lidocaine 照片 #1

United States

Company name: Fresenius Kabi USA
Brand name: Fresenius Kabi USA
Product recalled: Dexmedetomidine HCL in 0.9% Sodium Chloride Injection
Reason of the recall: Cross Contamination with Lidocaine
FDA Recall date: November 19, 2020
Recall details: Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to a trace amount of lidocaine present in the lot. This recall is being performed to the user level. To date, no adverse drug experience reports have been received for the recalled lot. Administration of Dexmedetomidine HCl containing trace amounts of lidocaine to a patient with lidocaine allergy could result in a potentially life-threatening allergic reaction.

Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection is approved for intravenous use and indicated for sedation of non-intubated patients prior to and/or during surgical and other procedures. Listed below is a table of the recalled lot distributed nationwide to wholesalers, distributors, hospitals and pharmacies between April 9, 2020 and April 13, 2020. An image of the label is also included below.

- Dexmedetomidine HCl in 0.9%. Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial. NDC Number: 63323-671-50. Product Code: 671050. Batch number: 6123925. Expiration Date: 03/2022. First Ship Date: 04/09/2020. Last Ship Date: 04/13/2020

Fresenius Kabi is notifying its distributors and customers by letter and asking them to check their stock immediately and to quarantine and discontinue the use and distribution of any affected product.

Distributors should notify their customers and direct them to quarantine and discontinue distributing or dispensing any affected lots, and to return the product to Fresenius Kabi.

Customers with questions regarding this recall may contact Fresenius Kabi at 1-866-716-2459 Monday through Friday, during the hours of 8:00 a.m. to 5:00 p.m. Central Time. Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking or using this drug product.

Check the full recall details on www.fda.gov

Source: FDA

#drugs #recall #crosscontamination #us

303

有帮助
跟随
添加报告
分享
- 复制链接

未订购的包裹, Palmer Street, Guelph, ON, Canada

2周前 •reported by user-bbnq8716

我收到了一个我没有订购的包裹，上面有我的名字和地址。

#unorderedpackage #delivery

87

有帮助
跟随
添加报告
分享
- 复制链接

未订购的包裹, Indianapolis, IN, USA

1周前 •reported by user-tryvb786

我收到了一个我没有订购的包裹。SUBGENIX
BIORIBOSE
通过激活 AMPK PSC-H' 促进多种代谢
提供非刺激性能量增强*
无论运动与不运动，都有益处*
膳食补充剂 D

#unorderedpackage #delivery #indianapolis #indiana #us

449

有帮助
跟随
添加报告
分享
- 复制链接

辛西娅·布兰查德和铜树管理价格塔, Bartlesville, Oklahoma, USA

3周前 •reported by user-bxhk3293

辛西娅·布兰查德（Cynthia Blanchard）说了一个又一个的谎言，要在一系列加密货币投资和房地产交易中通过电汇欺诈来偷钱。辛西娅·布兰查德通过电汇拿走了我们的钱，并通过加密货币拿走了更多钱，为我们提供了虚假的欺诈性股票、虚假的加密货币、由黄金支持的名为AGLD for anthemGold.com的虚假加密货币，这是一个缺失的网站。她的其他企业AnthemVault.com已经倒闭，即使是她声称与外国政府签有合同的HeraSoft.com也已停止营业，加利福尼亚州和能源部也已退出互联网并倒闭。她现在声称他们正在出售用我们的投资资本购买的本应作为公司总部的建筑，现在她正在俄克拉荷马州巴特尔斯维尔经营普华永道，这是一座由弗兰克·劳埃德·赖特建造的高层建筑，她说她以10美元的价格购买了这座建筑，如果我们想要钱，就需要在普华永道进行更多投资。欺诈、不诚实、虚假陈述已经够了。把钱还给我们然后直接去监狱你这个骗子！辛西娅·布兰查德是个骗子和骗子，她属于监狱！

#scam #bartlesville #oklahoma #us